BioXcel Therapeutics, Inc. BTAIQ
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Return on equity has no reading this year — return on capital employed, just below, still does: -1422%.
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.0 | 0.0 | · | · | · | · | · |
| Operating income $B | −0.1 | −0.1 | −0.2 | −0.2 | −0.1 | −0.1 | −0.0 | −0.0 | −0.0 |
| EBITDA $B | −0.1 | −0.1 | −0.2 | −0.2 | −0.1 | −0.1 | −0.0 | −0.0 | −0.0 |
| Income tax $B | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · |
| Net income $B | −0.1 | −0.1 | −0.2 | −0.2 | −0.1 | −0.1 | −0.0 | −0.0 | −0.0 |
| Free cash flow $B | −0.1 | −0.1 | −0.2 | −0.1 | −0.1 | −0.1 | −0.0 | −0.0 | · |
| EPS, diluted $ | −5.73 | −23.51 | −98.33 | −5.92 | −4.05 | −3.79 | −2.02 | −1.32 | −0.47 |
| Dividend / sh $ | · | · | · | · | · | · | · | · | · |
| Payout % | · | · | · | · | · | · | · | · | · |
| ROE % | · | · | −1766.9 | −111.1 | −49.9 | −70.4 | −100.2 | −101.7 | · |
| Shares out B | 0.02 | 0.00 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Reconciled in 9 of 19 fiscal years. 20 checks were skipped: the balance sheet is not tagged before 2017. 15 checks were skipped: revenue is not tagged before 2022. 10 checks were skipped: EPS is not tagged before 2017.